Zomedica Corp. Payments to Acquire Marketable Securities
Zomedica Corp. (ZOMDF) reported Payments to Acquire Marketable Securities of $8.07 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2023-05-11
- Zomedica Corp. payments to acquire marketable securities for the quarter ending 2023-03-31 was $8.07M.
- Zomedica Corp. payments to acquire marketable securities for the quarter ending 2022-12-31 was $14.56M.
- Zomedica Corp. payments to acquire marketable securities for fiscal 2022 was $127.79M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2023-03-31 | $8.07M 10-Q · filed 2023-05-11 | $22.63M derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2022-12-31 | $14.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $127.79M 10-K · filed 2023-03-15 | ||
| 2022-09-30 | $113.22M 10-Q · filed 2022-11-14 |